Skip to contentI
Immunic, Inc.
I
IMUXImmunic, Inc. Released May 9, 2017, after the close
10-Q filed May 9, 2017, 39 days after period end · 0001280776-17-000029
Q1 2017 · 10-Q
Revenue—
Net Income-$12.60M-$12.60MN/M vs Q1 2016N/M vs Q4 2016 EPS Diluted
No earnings release is on file for this quarter. Its figures came with the 10-Q.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR
-$0.39-$0.39N/M vs Q1 2016N/M vs Q4 2016 Operating Income-$12,687,000N/M Operating Cash Flow-$10,910,000N/M Free Cash Flowderived-$11,184,000N/M Filing lag
ended Mar 31, 2017 · filed May 9, 2017 · 39 d after period end